Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.01 USD | -1.27% | +2.94% | +7.85% |
04-30 | RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating | MT |
04-29 | Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.85% | 451M | |
+2.87% | 94.22B | |
-4.08% | 37.76B | |
-13.26% | 32.5B | |
+73.38% | 27.75B | |
-11.58% | 16.13B | |
-1.66% | 14.19B | |
-11.67% | 11.42B | |
+190.36% | 11.06B | |
-52.61% | 9.09B |
- Stock Market
- Equities
- CDMO Stock
- News Avid Bioservices, Inc.
- Avid Bioservices Prices $160 Million Convertible Notes Offering